Blood plasma specific fragment free DNA (deoxyribonucleic acid) quantitative detection kit

A quantitative detection and kit technology, which is applied in the field of analysis, can solve the problem of not being able to obtain information about large and small DNA fragments, and achieve the effect of removing errors and interference and good specificity
CN104073554AActive Publication Date: 2014-10-01JIANGSU MICRODIAG BIOMEDICINE TECH CO LTD
0 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
JIANGSU MICRODIAG BIOMEDICINE TECH CO LTD
Publication Date
2014-10-01

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a blood plasma specific fragment free DNA (deoxyribonucleic acid) quantitative detection kit comprising the following components: two primer pairs for amplifying TP53 gene fragments of which the lengths are respectively 400bp and 150bp, a primer pair for amplifying a reference gene Beta-actin, and fetal genome DNA, wherein the two primer pairs are consistent in backward primer sites, and the lengths of the amplified TP53 gene fragments are determined by virtue of a forward primer. According to the kit disclosed by the invention, a calibration system is introduced based on a fluorescent quantitative PCR (polymerase chain reaction) technology, the fetal genome DNA is used as background DNA, a house-keeping gene Beta-actin is used as the reference gene, a cancer suppressor gene TP53 is used as a target gene, an amplification primer is designed aiming at different lengths of fragments of the cancer suppressor gene TP53, different lengths of the fragments of the Beta-actin gene and the TP53 gene are synchronously amplified by adopting a real-time fluorescent quantitative PCR process, and the content of free DNA with specific fragment sizes in blood plasma can be quantitatively detected.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of analysis and relates to a DNA detection kit. Background technique

[0002] Cell-free DNA in peripheral blood refers to the partially degraded endogenous DNA in the peripheral blood that is free from the cells. There are three main sources: apoptosis, necrosis, and secretion.

[0003] In 1989, STROUN et al. found that the free DNA in the blood of tumor patients had some characteristics of tumor cell DNA, and thus proposed that the free DNA in the blood of tumor patients may be derived from tumor cells. Five years later, the researchers detected cancer gene mutations in the plasma and serum of tumor patients, and after spectral analysis, they found that they were consistent with the primary tumor. It has been confirmed that in the blood of tumor patients, the DNA with tumor biological characteristics is mainly derived from the natural distribution of tumor cells after necrosis and apoptosis or automatic r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More